A "combination oligonucleotide" antisense strategy to downregulate thymidylate synthase and decrease tumor cell growth and drug resistance.
about
Viral and non-viral vectors in gene therapy: technology development and clinical trials.Design and development of antisense drugs.Antisense targeting of thymidylate synthase (TS) mRNA increases TS gene transcription and TS protein: effects on human tumor cell sensitivity to TS enzyme-inhibiting drugs.Cancer: Towards a general theory of the target: All successful cancer therapies, actual or potential, are reducible to either (or both) of two fundamental strategies.
P2860
A "combination oligonucleotide" antisense strategy to downregulate thymidylate synthase and decrease tumor cell growth and drug resistance.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
A "combination oligonucleotide ...... ll growth and drug resistance.
@en
A "combination oligonucleotide ...... ll growth and drug resistance.
@nl
type
label
A "combination oligonucleotide ...... ll growth and drug resistance.
@en
A "combination oligonucleotide ...... ll growth and drug resistance.
@nl
prefLabel
A "combination oligonucleotide ...... ll growth and drug resistance.
@en
A "combination oligonucleotide ...... ll growth and drug resistance.
@nl
P2093
P2860
P356
P1433
P1476
A "combination oligonucleotide ...... ll growth and drug resistance.
@en
P2093
D James Koropatnick
Mark D Vincent
Peter J Ferguson
Randal W Berg
P2860
P2888
P304
P356
10.1038/SJ.CGT.7700566
P577
2003-04-01T00:00:00Z